IMARC Group’s report titled “Anti-infectives Market Report by Type (Antibacterial, Antifungal, Antiviral), Route of Administration (Topical, Oral, Intravenous (IV), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Speciality Pharmacies, Online Stores, and Others), and Region 2024-2032”. offers a comprehensive analysis of the industry, which comprises insights on the global anti-infectives market demand. The global market size reached US$ 134.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 177.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.05% during 2024-2032.
Grab a sample PDF of this report: https://www.imarcgroup.com/anti-infectives-market/requestsample
Factors Affecting the Growth of the Anti-Infectives Industry:
- Increasing Incidence of Infectious Diseases:
The rising incidence of infectious diseases worldwide due to factors, such as urbanization, increased international travel, and climate change, are contributing to the market growth. Diseases like tuberculosis, human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS), and malaria continue to pose notable public health challenges, particularly in low- and middle-income countries. These outbreaks not only increase the direct demand for anti-infective agents but also highlight the necessity for ongoing research and development (R&D) to combat emerging infectious threats. Governing bodies and health organizations are responding by investing in healthcare infrastructure and innovations in anti-infectives to address these challenges.
- Advancements in Antimicrobial Technologies:
Researchers are developing novel anti-infective agents, such as new classes of antibiotics, antivirals, and antifungals, to combat drug-resistant strains of pathogens. Innovative approaches, including the use of bacteriophage therapy, antimicrobial peptides, and the application of nanotechnology for targeted drug delivery, are enhancing the effectiveness and reducing the side effects of traditional treatments. Pharmaceutical companies are also leveraging genetic sequencing and bioinformatics to understand better pathogen mechanisms, which aids in the design of more effective drugs. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in drug discovery processes is accelerating the development of anti-infective drugs.
- Government Initiatives and Funding:
National and international health agencies are prioritizing the development of new anti-infective treatments due to the rising threat of drug-resistant bacteria and viruses. Programs that aim to bring new antibiotics to market by supporting small to medium-sized enterprises (SMEs) in advanced R&D stages are vital in this effort. Additionally, public health campaigns promote the rational use of antibiotics and regulations that encourage the development of new drugs. These initiatives are complemented by increased healthcare spending in many countries, focusing on improving public health outcomes and supporting the growth of the pharmaceutical industry in the anti-infective sector.
Leading Companies Operating in the Global Anti-Infectives Industry:
- Abbott Laboratories
- Cipla Health Ltd. (Cipla Limited)
- F. Hoffmann-La Roche AG
- GlaxoSmithKline plc
- Glenmark Pharmaceuticals Limited
- Johnson & Johnson
- Lupin Limited
- Sandoz AG (Novartis AG)
- Sun Pharmaceutical Industries Limited
Anti-Infectives Market Report Segmentation:
By Type:
- Antibacterial
- Antifungal
- Antiviral
Antiviral exhibits a clear dominance in the market due to its critical role in managing and treating viral infections.
By Route of Administration:
- Topical
- Oral
- Intravenous (IV)
- Others
Oral represents the largest segment attributed to its convenience, cost-effectiveness, and preference by patients for home treatment compared to injectable forms.
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Speciality Pharmacies
- Online Stores
- Others
Hospital pharmacies hold the biggest market share, they are essential points of access for patient-specific formulations and immediate drug needs.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America dominates the market owing to its advanced healthcare infrastructure, rising investment in pharmaceutical R&D, and a strong presence of leading drug manufacturers.
Global Anti-Infectives Market Trends:
The growing focus on combination therapies, which involve the use of two or more antibiotics or antivirals to treat complex infections, is offering a favorable market outlook. This approach not only enhances the efficacy of treatments by targeting multiple pathways of the pathogen but also helps in reducing the risk of developing further resistance.
Furthermore, there is an interest in personalized medicine in the field of anti-infectives. Advances in genomics and biotechnology enable healthcare providers to tailor treatments based on individual patient profiles and the genetic characteristics of the infecting organism, providing more effective and efficient care.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
